WASHINGTON – Sen. Chris Murphy, who says the nomination is in trouble, on Wednesday questioned Rex Tillerson, Donald Trump’s pick to head the State Department, about a dossier of unverified allegations that Russian operatives have been helping the president-elect for years and have compromising information about him. “The report is as earth-shattering as it is thinly sourced,” Murphy said. “We all pray it is untrue.”
January 11, 2017
Trump takes another shot at F-35 program
WASHINGTON — President-elect Donald Trump took another swipe at the F-35 program Wednesday during his first press conference since November’s election. “It’s way behind schedule and billions of dollars over budget,” Trump said. “I don’t like that.”
Malloy won’t reassure CT towns they are safe from the budget axe
Gov. Dannel P. Malloy offered worried municipal leaders Wednesday no assurances they would be spared from cuts to local aid as he and the General Assembly grapple with another major deficit in the next state budget.
Why I march
Since the Women’s March on Washington began, perhaps the biggest question has been: Why March? We are a large group of women throughout the state of Connecticut who woke up on November 9 with the realization that something unique had occurred. We each woke up the day after the election feeling like strangers in an alien land. A call to move from despondency to recovery and resistance, created a need to reach out and join forces that ultimately coalesced in the March on Washington on January 21. While, as individuals, we may have joined this effort for different reasons, we have organized around three principles: We march to support each other and remind ourselves that we are not alone. We march to send a clear message that the new administration has no mandate. We march to organize for a better future.
How can states tackle rising medication prices?
There’s a bully pulpit approach – think President-elect Donald J. Trump, who blasted pharmaceutical companies Wednesday – or the more industry-friendly concept of tying payments to whether the drugs deliver value, like fewer hospitalizations. There’s proposing legislation to increase transparency in drug pricing, or treating certain medications as critical goods that should be regulated like water and electricity.